Breast MRI - The champion in the millimeter league MIO breast MRI - The method of choice in women with dense breasts

被引:2
作者
Fischer, Uwe [1 ]
机构
[1] Diagnost Breast Care Ctr, Bahnhofsallee 1d, D-37081 Gottingen, Germany
关键词
Breast Carcinoma; MRI; Breast MRI; MR-guided intervention; CONTRAST-MEDIUM ENHANCEMENT; CLINICAL-PERFORMANCE; DIAGNOSTIC-ACCURACY; MAMMOGRAPHY; CANCER; BIOPSY; TOMOSYNTHESIS; MULTICENTER; PROTOCOL; LESIONS;
D O I
10.1016/j.ejrad.2023.111053
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
We perform MRI of the breast as a first pass technique. We successfully established 10-minute-protocols (including T2 images) with a fixed dosage of 5 ml 1 M CM. A high spatial resolution of 526 x 526, better 672 x 672 or maximum (1.024 x 1.024, MIO MRI) is vital to achieve best results. We use fixation tools to avoid motion artifacts. Motion correction algorithms can, however, often eliminate such artifacts when they are present. In initial breast MRI exams, morphologic features are the most important criteria for lesion evaluation. If previous exams are available for comparison, the main criteria indicating a suspicious lesion are an increase in lesion size or the depiction of new lesions.High quality HR MRI of the breast is the method of choice in women with dense or extremely dense breasts in all cases (screening, assessment, follow up). In density type A or B, MRI can be helpful in defined constellations, e.g. when MX and US are limited or contraindicated.According to our experience, 95% or more of all carcinomas of the breast are detectable on MRI. The remaining 5% of MRI-occult lesions are intraductal tumors or very small invasive carcinomas depicted with mammography due to associated microcalcifications. MRI is, however, superior to all other imaging modalities in the detection of the clinically relevant DCIS (high risk DCIS, intermediate type).Consecutive MRI examinations in intervals of 12 to 24 months allow a reliable detection of invasive breast cancer with an average size of 7-8 mm. This corresponds to a rate of metastasis-free locoregional lymph nodes in >95% of cases. The rate of interval cancers is <2%. In conclusion, this strategy may increase the overall-lifetime survival of breast cancer patients to more than 95%. Inversely, mortality may be reduced to <5%.Taking these improvements in early breast cancer detection and survival that can be achieved through the implementation of QA HR MRI of the breast into account, it should be discussed to modify oncologic guidelines for the treatment of breast cancer.MRI is the best diagnostic tool we have and according to our experience, a first pass, quality-assured high-resolution breast MRI protocol provides best diagnostic results at minimal procedural effort.
引用
收藏
页数:33
相关论文
共 68 条
[1]  
Al-Khawari Hanaa, 2009, Hematol Oncol Stem Cell Ther, V2, P403
[2]  
American College of Radiology (ACR), 2013, Breast Imaging Reporting and Data System Atlas (BI-RADS Atlas)
[3]  
[Anonymous], 2020, INTERDISZIPLINARE S3
[4]  
[Anonymous], 2021, Mammo Report.
[5]   Supplemental MRI Screening for Women with Extremely Dense Breast Tissue [J].
Bakker, Marije F. ;
de Lange, Stephanie V. ;
Pijnappel, Ruud M. ;
Mann, Ritse M. ;
Peeters, Petra H. M. ;
Monninkhof, Evelyn M. ;
Emaus, Marleen J. ;
Loo, Claudette E. ;
Bisschops, Robertus H. C. ;
Lobbes, Marc B. I. ;
de Jong, Matthijn D. F. ;
Duvivier, Katya M. ;
Veltman, Jeroen ;
Karssemeijer, Nico ;
de Koning, Harry J. ;
van Diest, Paul J. ;
Mali, Willem P. T. M. ;
van den Bosch, Maurice A. A. J. ;
Veldhuis, Wouter B. ;
van Gils, Carla H. .
NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (22) :2091-2102
[6]   Clinical MR Mammography: Impact of Hormonal Status on Background Enhancement and Diagnostic Accuracy [J].
Baltzer, P. A. ;
Dietzel, M. ;
Vag, T. ;
Burmeister, H. ;
Gajda, M. ;
Camara, O. ;
Pfleiderer, S. O. ;
Kaiser, W. A. .
ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN, 2011, 183 (05) :441-447
[7]   Diffusion-weighted imaging of the breast-a consensus and mission statement from the EUSOBI International Breast Diffusion-Weighted Imaging working group [J].
Baltzer, Pascal ;
Mann, Ritse M. ;
Iima, Mami ;
Sigmund, Eric E. ;
Clauser, Paola ;
Gilbert, Fiona J. ;
Martincich, Laura ;
Partridge, Savannah C. ;
Patterson, Andrew ;
Pinker, Katja ;
Thibault, Fabienne ;
Camps-Herrero, Julia ;
Le Bihan, Denis .
EUROPEAN RADIOLOGY, 2020, 30 (03) :1436-1450
[8]   Imaging signs and radiologists' jargon of ruptured breast implants [J].
Beekman, WH ;
van Straalen, WR ;
Hage, JJ ;
van Amerongen, AHMT ;
Mulder, JW .
PLASTIC AND RECONSTRUCTIVE SURGERY, 1998, 102 (04) :1281-1289
[9]   Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer [J].
Berg, WA ;
Gutierrez, L ;
NessAiver, MS ;
Carter, WB ;
Bhargavan, M ;
Lewis, RS ;
Ioffe, OB .
RADIOLOGY, 2004, 233 (03) :830-849
[10]   Diagnostic Performance of MRI Versus Galactography in Women With Pathologic Nipple Discharge: A Systematic Review and Meta-Analysis [J].
Berger, Nicole ;
Luparia, Andrea ;
Di Leo, Giovanni ;
Carbonaro, Luca Alessandro ;
Trimboli, Rubina Manuela ;
Ambrogi, Federico ;
Sardanelli, Francesco .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2017, 209 (02) :465-471